ORIGINAL RESEARCH article
Front. Digit. Health
Sec. Human Factors and Digital Health
Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1672732
This article is part of the Research TopicDesigning for Engagement in Digital Health for Chronic and Long-Term CareView all 13 articles
From Implementation to Discontinuation: Multi-Year Experience with the Multiple Sclerosis Performance Test as a Digital Monitoring Tool
Provisionally accepted
- Center of Clinical Neuroscience, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ABSTRACT Introduction: Digital tools such as the self-administered Multiple Sclerosis Performance Test (MSPT) support structured monitoring of multiple sclerosis (MS) through standardized assessments of motor, visual, and cognitive functions. Despite clinical validity and adoption, real-world data on long-term user experiences and the consequences of discontinuing MSPT-based monitoring in routine care are lacking. Objective: This study aimed to assess multi-year user experiences with the MSPT among patients and neurologists, investigate patient perceptions following its discontinuation from clinical care, and evaluate preferences for future MSPT-like digital tools. Methods: This observational, repeated cross-sectional study involved three questionnaire-based surveys. In 2020, separate surveys of patients and neurologists (combined n = 210) evaluated sustained MSPT use in routine care. Following the cessation of funding and subsequent discontinuation of MSPT from clinical workflows in 2023, a patient survey was conducted in 2024 (n = 144) to evaluate the impact of this withdrawal and preferences for future digital monitoring tools. Quantitative analyses included frequency distributions, Net Promoter Score (NPS) categorization, correlational analyses, and descriptive data visualization. Results: Patients reported high satisfaction with MSPT usability, utility for disease monitoring, administration frequency, time efficiency, physical and cognitive demands, and suitability for unsupervised tablet-based use. Most viewed discontinuation from their clinical care negatively and favored reintroducing similar tools, either in clinic (85.5%) or at home (78.6%). Those who dissented cited time savings and sufficient physician feedback. Discussion: Prolonged MSPT use is associated with strong patient and clinician acceptance. Findings support the continued integration of digital monitoring tools into MS care and emphasize the importance of patient perspectives in their design.
Keywords: digital monitoring tools, Multiple Sclerosis, MSPT, patient perceptions, digital tools
Received: 24 Jul 2025; Accepted: 08 Sep 2025.
Copyright: © 2025 Schriefer, Dillenseger, Atta, Inojosa and Ziemssen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Tjalf Ziemssen, Center of Clinical Neuroscience, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.